Insights On Partnering

  1. Unlocking The Benefits Of Site Payment Platforms: Part 1 12/5/2025

    By standardizing workflows, ensuring audit-ready documentation, and providing actionable real-time insights, these platforms mitigate operational risks while supporting better financial oversight.

  2. CDMO Support: Success In Early-Phase Drug Product Development 4/17/2024

    As sponsors strive to deliver therapies with increasing efficiency, CDMOs are poised to remain vital, offering specialized expertise, accelerated timelines, cost efficiency, and risk mitigation.

  3. Finding The Right CRO Partner For Early-Stage Oncology Trials 11/21/2025

    Discover how a data-driven CRO selection framework can replace manual processes, minimize bias, and build stronger, more collaborative sponsor–vendor relationships.

  4. Why Asia Should Be Your Next Trial Destination 10/17/2025

    Many U.S. oncology sponsors are expanding their late-phase trials into Asia to secure access to rich patient pools, leverage efficient regulatory pathways, and save time and money in the clinic.

  5. Creating Operational Efficiency And Competitive Edge 9/10/2025

    Site networks offer a strategic approach to oncology clinical trials by accelerating study startup and expanding access to diverse patient populations.

  6. Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection 7/1/2025

    Starting a new clinical study requires careful vendor selection and these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.

  7. Why Bioanalysis Needs To Break Free From Manual Bottlenecks 9/2/2025

    Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.

  8. Expand Bandwidth With A Trusted Regulatory Writing Partner 9/18/2025

    Find out how a mid-size biotech lacking the bandwidth, expertise, and resources to independently handle its regulatory writing requirements overcame this challenge.

  9. How To Capture Growth In The Expanding Metabolic Drug Market 12/2/2025

    Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.

  10. How Can Sponsors Enable Research-Naïve Clinical Trial Sites 8/8/2025

    Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.